Abstract
Introduction

47
During the initiation of pregnancy, the human blastocyst must implant into the uterus in 
53
Implantation is initiated during the 'window of implantation', a specific period during the 54 menstrual cycle where the uterus is receptive to the blastocyst (3) . To become receptive, the 55 luminal and glandular epithelium undergo significant changes, particularly with respect to 56 their secretory capacity and adhesion molecule expression (3) , facilitating the adhesion of 57 two epithelial surfaces; the blastocyst trophectoderm and the uterine luminal epithelium.
58
Adhesion molecules such as mucins, glycoconjugates, trophinin, cadherins and integrins are 59 all regulated during the window of implantation (3) .
60
While implantation failure results in infertility, impaired implantation results in inadequate 61 placentation and associated conditions including early miscarriage (4). More recently, it has 62 been proposed that recurrent miscarriage [defined as 3 or more consecutive miscarriages 63 (5)] is associated with abnormalities in endometrial receptivity that lead to inappropriate 64 implantation and subsequent miscarriage (6). Certainly, both the endometrial epithelium M A N U S C R I P T
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4 upregulated in the human endometrial epithelium during the secretory phase (15) and in 73 mice decreased implantation is found following tissue specific knockdown of galectin-3 (16).
74
Further, an association with spontaneous abortion and a splice variant of galectin-9 is found 75 in both mice and women (17), indicating critical roles for at least these lectins in 76 implantation.
77
Galectin-7 is a 15kDa protein originally identified in the epidermis. It is generally expressed 78 by epithelial cells and localizes to areas of cell-cell contact (9). It is a prototype galectin 79 found as both a monomer and a dimer (18) 
96
Methods
97
Ethical approvals 
120
The serum used in this study was from a Biobank of serum samples prospectively collected
121
from the mid to late first trimester specifically to investigate miscarriage ( Table 2 ). Serum
122
was collected from pregnant women between weeks 6-10 of gestation as previously 
126
Miscarriage was defined as the loss of the pregnancy at less than 20 weeks gestation (22 
141
Immunostaining intensity in the endometrium was analysed semiquantitively by two 142 independent and blinded observers as previously described (23). The intensity of galectin-7 143 staining in the endometrium was assessed and allocated a score between 0 (no staining) and 144 3 (strong staining) relative to positive and negative controls.
146
Galectin 7 ELISA
147
The serum concentration of galectin-7 was assayed using the RayBio ® Human Galectin-7
148
ELISA (ELH-Galectin7-001) according to the manufacturer's instructions. Briefly, neat serum 149 diluted 1:4 with diluent (provided) was incubated on a rotating shaker for 2h before binding
was detected using kit components. The plate was read at 450nm (Envision, Perkin Elmer) 151 and the data analysed using the RayBio ELISA analysis tool (Excel). 
treatments. The purity of primary trophoblasts (hT) was confirmed by immunocytochemistry 177 for HLAG (BD Biosciences, CA, USA) as previously described (26).
179
Cell-cell adhesion assays
180
Galectin-7 regulation of adhesion was performed using a cell-cell adhesion assay as 181 previously described (25, 27 
209
Non-pregnant endometrium of women with a history of miscarriage
210
We compared the galectin-7 endometrial staining intensity in non-pregnant, normally fertile
211
women to non-pregnant women who had previously had at least two miscarriages.
212
Endometrial galectin-7 staining intensity was significantly higher in women who had 
222
Galectin-7 serum concentration was predictive of miscarriage at 6 weeks gestation.
223
To determine whether galectin-7 serum concentration could predict subsequent 224 miscarriage, the concentration of galectin-7 was measured in serum from non-pregnant 225 women and serum prospectively collected across weeks 6-10 of pregnancy ( Figure 2A ).
226
Serum concentration of galectin-7 did not change across gestational weeks 6-10 in normal 227 pregnancies (Figure 2A ). At week 6, the serum concentration of galectin-7 was significantly M A N U S C R I P T
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higher in women who went on to miscarry before 20 weeks than those that had a normal 229 pregnancy ( Figure 2B ; p<0.05).
231
Galectin-7 strongly localized to the region of placental-endometrial attachment
232
As galectins are implicated in cell-cell interactions we investigated whether galectin-7 was 233 present in vivo in the region of trophoblast-endometrial attachment and invasion.
234
Immunohistochemistry of first trimester placenta showed strong localization of galectin-7 to 235 the syncytiotrophoblast in the placenta and to EVTs in the cell column ( Figure 3 ).
237
Galectin-7 regulates trophoblast -epithelial adhesion
238
Given that galectin-7 strongly localized to the region of fetal-maternal attachment, we 239 aimed to model attachment of trophoblast to the endometrium in vitro using a cell-cell 
243
Treatment of ECC1 or HTR8/Svneo cells with galectin-7 had no effect on HTR8/Svneo-ECC1 244 adhesion ( Figure 4A ), however combined treatment of HTR8/Svneo and ECC1 cells with 
250
When the adhesion assay was performed using hEEC monolayers were derived from pools of 251 women who were normally fertile and/or who had unexplained primary infertility we 252 confirmed the cell line data, whereby galectin-7 suppressed trophoblast-epithelial adhesion
253
( Figure 4B , black bars, n=2). However, when these cell-cell adhesion experiments were M A N U S C R I P T 
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269
The serum concentration of galectin-7 was significantly up-regulated at week 6 of gestation 270 in women with a viable fetus at the time of blood collection that were destined to miscarry 271 compared to normal healthy pregnancies. This very early gestation specific increase 272 supports our hypothesis that excess galectin-7 plays an important role in trophoblast-
273
endometrial adhesion. It is unclear from our data the origin of the elevated serum galectin-
274
7. Galectin-7 localises to the syncytiotrophoblast in the placenta and glandular epithelium in 275 the decidua of early pregnancy , suggesting it may have a placental origin. The serum utilized 276 in this study has previously been used to investigate the expression of many serum proteins
277
in women who go on to miscarry (22, 28) . In these studies IL33 is elevated, ST2 and
278
ananamide show no effect and hCG, MIC-1 and PAPP-A are depressed in women who M A N U S C R I P T 
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292
supporting a role for galectin-7 in mediating adhesion at physiological concentrations.
294
In contrast, pre-treatment with galectin-7 to the primary cultures isolated from women with 
311
Proteins up-and down-stream of galectin-7 have also been implicated in implantation 
321
Another important role for galectins is modulating the immune response (12, 13, 36, 37) .
322
Immunologic dysregulation has been proposed as a cause of recurrent miscarriage (38).
323
Galectin-7 is a T-cell binding protein (39) and is upregulated in mice with cardiac allografts 324 undergoing acute rejection compared to isograft controls (40). Importantly, galectin-7 levels 325 increased with the level of acute rejection (40) and it was previously shown by proteomics to 326 be upregulated in the serum of renal graft recipients compared to normal volunteers (41).
327
Further studies are required to determine whether serum levels of galectin-7 are associated 328 with abberent T cell activation in pregnancies that go on to miscarry. 
10
women with a history of miscarriage (red) and women with unexplained primary infertility
11
(blue).
12
I. Immunoscoring of galectin-7 in the glandular epithelium of normally fertile women (black),
13
women with a history of miscarriage (red) and women with unexplained primary infertility 14 (blue).
15
J. Immunoscoring of galectin-7 in the stroma of normally fertile women (black), women with 16 a history of miscarriage (red) and women with unexplained primary infertility (blue). 
22
A. Serum concentration at in non-pregnant women and women at weeks 6-10 of 23 gestation.
24
B. Serum concentration at week 6 of gestation only. 
29
Galectin-7 immunolocalised to the syncytiotrophoblast (st), the cell column (cc) and to
30
extravillous trophoblast (evt) in first trimester placental tissue.
31
Negative IgG control is shown below. 
